191 / 260
Čȴ GūƑĚĿijŠ ČƭƑƑĚŠČNj ƥƑîŠƙîČƥĿūŠƙȠ
i)
Functional and presentation currency:
Items included in the Financial Statements of each entities of the Group are measured using the currency of the
primary economic environment in which the Company operates (‘functional currency’). The Consolidated Financial
Statements are presented in Indian currency (
`
), which is also the functional and presentation currency of the
Company.
ii) Transactions and balances:
GūƑĚĿijŠ ČƭƑƑĚŠČNj ƥƑîŠƙîČƥĿūŠƙ îƑĚ ƥƑîŠƙŕîƥĚē ĿŠƥū ƥĺĚ ljƭŠČƥĿūŠîŕ ČƭƑƑĚŠČNj ƭƙĿŠij ƥĺĚ ĚNJČĺîŠijĚ ƑîƥĚƙ îƥ ƥĺĚ ēîƥĚƙ ūlj
ƥĺĚ ƥƑîŠƙîČƥĿūŠƙȦ GūƑĚĿijŠ ĚNJČĺîŠijĚ ijîĿŠƙ îŠē ŕūƙƙĚƙ ƑĚƙƭŕƥĿŠij ljƑūŞ ƥĺĚ ƙĚƥƥŕĚŞĚŠƥ ūlj ƙƭČĺ ƥƑîŠƙîČƥĿūŠƙ îŠē ljƑūŞ
ƥĺĚ ƥƑîŠƙŕîƥĿūŠ ūlj ŞūŠĚƥîƑNj îƙƙĚƥƙ îŠē ŕĿîċĿŕĿƥĿĚƙ ēĚŠūŞĿŠîƥĚē ĿŠ ljūƑĚĿijŠ ČƭƑƑĚŠČĿĚƙ îƥ NjĚîƑ ĚŠē ĚNJČĺîŠijĚ ƑîƥĚƙ îƑĚ
ijĚŠĚƑîŕŕNj ƑĚČūijŠĿƙĚē ĿŠ ƥĺĚ ūŠƙūŕĿēƥîĚē ¬ƥîƥĚŞĚŠƥ ūlj ¡ƑūǛƥ îŠē gūƙƙ ĚNJČĚƎƥ ƥĺîƥ ƥĺĚNj îƑĚ ēĚljĚƑƑĚē ĿŠ ĚƐƭĿƥNj Ŀlj ƥĺĚNj
ƑĚŕîƥĚ ƥū ƐƭîŕĿljNjĿŠij Čîƙĺ ǜūDž ĺĚēijĚƙȦ
GūƑĚĿijŠ ĚNJČĺîŠijĚ ēĿljljĚƑĚŠČĚƙ ƑĚijîƑēĚē îƙ îŠ îēŏƭƙƥŞĚŠƥ ƥū ċūƑƑūDžĿŠij Čūƙƥƙ îƑĚ ƎƑĚƙĚŠƥĚē ĿŠ ƥĺĚ ūŠƙūŕĿēîƥĚē
¬ƥîƥĚŞĚŠƥ ūlj ¡ƑūǛƥ îŠē gūƙƙȡ DžĿƥĺĿŠ ǛŠîŠČĚ ČūƙƥƙȦ ŕŕ ūƥĺĚƑ ljūƑĚĿijŠ ĚNJČĺîŠijĚ ijîĿŠƙ îŠē ŕūƙƙĚƙ îƑĚ ƎƑĚƙĚŠƥĚē ĿŠ ƥĺĚ
ūŠƙūŕĿēîƥĚē ¬ƥîƥĚŞĚŠƥ ūlj ¡ƑūǛƥ îŠē gūƙƙ ūŠ î ŠĚƥ ċîƙĿƙ DžĿƥĺĿŠ ūƥĺĚƑ ĿŠČūŞĚ ʈ ȳĚNJƎĚŠƙĚȴȦ
Non-monetary items that are measured at fair value that are denominated in a foreign currency are translated using
ƥĺĚ ĚNJČĺîŠijĚ ƑîƥĚƙ îƥ ƥĺĚ ēîƥĚ DžĺĚŠ ƥĺĚ ljîĿƑ DŽîŕƭĚ Džîƙ ēĚƥĚƑŞĿŠĚēȦ ¹ƑîŠƙŕîƥĿūŠ ēĿljljĚƑĚŠČĚƙ ūŠ îƙƙĚƥƙ îŠē ŕĿîċĿŕĿƥĿĚƙ
carried at fair value are reported as part of the fair value gain | (loss).
iii) Group companies:
¹ĺĚ ƑĚƙƭŕƥƙ îŠē ǛŠîŠČĿîŕ ƎūƙĿƥĿūŠ ūlj ljūƑĚĿijŠ ūƎĚƑîƥĿūŠƙ ȳŠūŠĚ ūlj DžĺĿČĺ ĺîƙ ƥĺĚ ČƭƑƑĚŠČNj ūlj î ĺNjƎĚƑĿŠǜîƥĿūŠîƑNj ĚČūŠūŞNjȴ
that have a functional currency different from the presentation currency are translated into the presentation currency
as follows:
a) assets and liabilities are translated at the closing rate at the date of that Balance Sheet
ċȴ ĿŠČūŞĚ îŠē ĚNJƎĚŠƙĚƙ îƑĚ ƥƑîŠƙŕîƥĚē îƥ îDŽĚƑîijĚ ĚNJČĺîŠijĚ ƑîƥĚƙ ȳƭŠŕĚƙƙ ƥĺĿƙ Ŀƙ Šūƥ î ƑĚîƙūŠîċŕĚ îƎƎƑūNJĿŞîƥĿūŠ
of the cumulative)
Čȴ îŕŕ ƑĚƙƭŕƥĿŠij ĚNJČĺîŠijĚ ēĿljljĚƑĚŠČĚƙ îƑĚ ƑĚČūijŠĿƙĚē ĿŠ ūƥĺĚƑ ČūŞƎƑĚĺĚŠƙĿDŽĚ ĿŠČūŞĚ
ØĺĚŠ î ljūƑĚĿijŠ ūƎĚƑîƥĿūŠ Ŀƙ ēĿƙƎūƙĚēȡ ƥĺĚ îƙƙūČĿîƥĚē ĚNJČĺîŠijĚ ēĿljljĚƑĚŠČĚƙ îƑĚ ƑĚČŕîƙƙĿǛĚē ƥū ƥĺĚ ūŠƙūŕĿēîƥĚē
¬ƥîƥĚŞĚŠƥ ūlj ¡ƑūǛƥ îŠē gūƙƙȡ îƙ ƎîƑƥ ūlj ƥĺĚ ijîĿŠ ʈ ȳŕūƙƙȴ ūŠ ƙîŕĚȦ HūūēDžĿŕŕ îŠē ljîĿƑ DŽîŕƭĚ îēŏƭƙƥŞĚŠƥƙ îƑĿƙĿŠij ūŠ ƥĺĚ
acquisition of a foreign operation are treated as assets and liabilities of the foreign operation and translated at the
closing rate.
ēȴ ¤ĚDŽĚŠƭĚ ƑĚČūijŠĿƥĿūŠȠ
i)
Revenue from contracts with customers:
¹ĺĚ HƑūƭƎ îēūƎƥĚē TŠē ¬ ǧǧǫȡ Ƀ¤ĚDŽĚŠƭĚ ljƑūŞ ūŠƥƑîČƥƙ DžĿƥĺ ƭƙƥūŞĚƑƙɄ ƭƙĿŠij ƥĺĚ ŞūēĿǛĚē ƑĚƥƑūƙƎĚČƥĿDŽĚ ƥƑîŠƙĿƥĿūŠ
method effective April 01, 2018. Refer Note 29.18 for details of impact on the Financial Statements on account of the
transition.
The Group manufactures and sells chemicals in domestic and international market, spread across two segments
namely Life Sciences Chemicals and Performance and Other Chemicals.
Revenue is recognised when control of goods is transferred to a customer in accordance with the terms of the
contract. The control of the goods is transferred upon delivery to the customers either at factory gate of the Group
ūƑ ƙƎĚČĿǛČ ŕūČîƥĿūŠ ūlj ƥĺĚ ČƭƙƥūŞĚƑ ūƑ DžĺĚŠ ƥĺĚ ijūūēƙ îƑĚ ĺîŠēĚē ūDŽĚƑ ƥū ƥĺĚ ljƑĚĿijĺƥ ČîƑƑĿĚƑȡ îƙ ƎĚƑ ƥĺĚ ƥĚƑŞƙ ūlj ƥĺĚ
contract. A receivable is recognised by the Group when the goods are delivered to the customer as this represents
the point in time at which the right to consideration becomes unconditional, as only the passage of time is required
before payment is due.
Consolidated
|
Notes to the Financial Statements
189